[1. Al-Rifai RH, Pearson F, Critchley J, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2017;12: e0187967.10.1371/journal.pone.0187967569782529161276]Search in Google Scholar
[2. Syal K, Srinivasan A, Banerjee D. VDR, RXR, coronin-1 and inter-feron ɤ levels in PBMCs of type-2 diabetes patients: molecular link between diabetes and tuberculosis. Indian Journal of Clinical Biochemistry. 2015;30(3): 323–328.10.1007/s12291-014-0431-7446906426089620]Search in Google Scholar
[3. Harries AD, Lin Y, Kumar AMV, Satyanarayana S, Zachariah R, Dlodlo RA. How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS? The International Journal of Tuberculosis and Lung Disease. 2018;22: 1117–1126.]Search in Google Scholar
[4. Koesoemadinata RC, Kranzer K, Livia R, Susilawati N, Annisa J, Soetedjo NNM, et al. Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus. The International Journal of Tuberculosis and Lung Disease. 2018;22: 1088–1094.10.5588/ijtld.17.082730092877]Search in Google Scholar
[5. Jain KK, Thakuria R, Lokesh S. Prevalence of pulmonary diabetes mellitus in tuberculosis patients attending tertiary care institute. International Medical Journal. 2015;2(4): 245–248.]Search in Google Scholar
[6. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, Van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health. 2010;12(11): 1289–1299.10.1111/j.1365-3156.2010.02625.x20955495]Search in Google Scholar
[7. Liu Q, Li W, Xue M, Chen Y, Du X, Wang C, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Scientific Reports. 2017;7: 1090.10.1038/s41598-017-01213-5543079728439071]Search in Google Scholar
[8. American Diabetes Association. Standards of medical care in diabetes-2019 abridged for primary care providers. Clinical Diabetes. 2019;37(1): 11–34.10.2337/cd18-0105633611930705493]Search in Google Scholar
[9. Semianiv I, Todoriko L, Ieremenchuk I. Prevention of adverse reactions due to pharmacotherapy in MRTB considering polymorphism of glutathione-S-transferase M1 and T1 genes. Europen Respiratory Journal. 2017;49: 60.]Search in Google Scholar
[10. Todoriko LD. Immunopathogenesis of drug-resistant tuberculosis present position. Tuberculosis Lung Disease HIV-Infection. 2017;3(30): 92–98.]Search in Google Scholar
[11. World Health Organization. Rapid Communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). August 2018. WHO/CDS/TB/2018.18.]Search in Google Scholar